The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Undertreatment of Obese Women Receiving Breast Cancer Chemotherapy
Abstract
BACKGROUND: Systematic undertreatment of breast cancer in overweight and obese women may contribute to the poorer prognosis in these women. The objective of this study was to investigate treatment patterns in overweight and obese women undergoing breast cancer adjuvant chemotherapy. METHODS: We performed a retrospective cohort study of 9672 women treated with doxorubicin hydrochloride and cyclophosphamide between 1990 and 2001. The main outcome measure was the quality of chemotherapy as measured by the use of reduced doses for the first treatment (compared with standard doses), the overall dose proportion (actual-expected dose ratio), and relative dose intensity. RESULTS: First-cycle dose reductions (defined as a dose proportion of <0.9 compared with standard published doses) were administered to 9% of the healthy weight, 11% of the overweight, 20% of the obese, and 37% of the severely obese women (P<.001). First-cycle reduction was independently associated with being overweight (P = .03), obese (P<.001), severely obese (P<.001), older than 60 years (P<.001), and having a serious comorbid condition (P = .03). Practices varied greatly in the use of dose reductions in overweight and obese patients. Severe obesity was independently associated with a lower likelihood of admission for febrile neutropenia, even among those subjects given full weight-based doses (odds ratio, 0.61; 95% confidence interval, 0.38-0.97). CONCLUSIONS: Overweight and obese women with breast cancer often receive intentionally reduced doses of adjuvant chemotherapy. Administration of initial and overall full weight-based doses of adjuvant chemotherapy in overweight and obese women is likely to improve outcomes in this group of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003) · JAMA · doi:10.1001/jama.289.1.76 · Cited by 5,866
Wennberg, J., & Gittelsohn, A. (1973) · Science · doi:10.1126/science.182.4117.1102 · Cited by 1,876
Citron, M. L., Berry, D. A., Cirrincione, C., Hudis, C., Winer, E. P., Gradishar, W. J., Davidson, N. E., Martino, S., Livingston, R., Ingle, J. N., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.081 · Cited by 1,564
Bonadonna, G., Valagussa, P., Moliterni, A., Zambetti, M., & Brambilla, C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321401 · Cited by 1,049
Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., & Hood, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.42 · Cited by 981
Unwarranted variations in healthcare delivery: implications for academic medical centres
Wennberg, J. E. (2002) · BMJ · doi:10.1136/bmj.325.7370.961 · Cited by 812
Dose-Response Effect of Adjuvant Chemotherapy in Breast Cancer
Bonadonna, G., & Valagussa, P. (1981) · New England Journal of Medicine · doi:10.1056/nejm198101013040103 · Cited by 774
Fisher, B., Brown, A. M., Dimitrov, N. V., Poisson, R., Redmond, C., Margolese, R. G., Bowman, D., Wolmark, N., Wickerham, D. L., & Kardinal, C. G. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.9.1483 · Cited by 620
Dose and Dose Intensity as Determinants of Outcome in the Adjuvant Treatment of Breast Cancer
Budman, D. R., Berry, D. A., Cirrincione, C. T., Henderson, Wood, W. C., Weiss, R. B., Ferree, C. R., Muss, H. B., Green, M. R., Norton, L., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.16.1205 · Cited by 577
Variations in Physician Practice: The Role of Uncertainty
Eddy, D. M. (1984) · Health Affairs · doi:10.1377/hlthaff.3.2.74 · Cited by 569
Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma
(1994) · New England Journal of Medicine · doi:10.1056/nejm199407143310226 · Cited by 556
Increases in Clinically Severe Obesity in the United States, 1986-2000
Sturm, R. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.18.2146 · Cited by 542
Nutrition and Survival After the Diagnosis of Breast Cancer: A Review of the Evidence
Rock, C. L., & Demark-Wahnefried, W. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.03.008 · Cited by 412
Adiposity and Sex Hormones in Postmenopausal Breast Cancer Survivors
McTiernan, A., Rajan, K. B., Tworoger, S. S., Irwin, M., Bernstein, L., Baumgartner, R., Gilliland, F., Stanczyk, F. Z., Yasui, Y., & Ballard-Barbash, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.057 · Cited by 278
Doxorubicin clearance in the obese.
Rodvold, K. A., Rushing, D. A., & Tewksbury, D. A. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.8.1321 · Cited by 213
Racial Disparity in the Dose and Dose Intensity of Breast Cancer Adjuvant Chemotherapy
Griggs, J. J., Sorbero, M. E. S., Stark, A. T., Heininger, S. E., & Dick, A. W. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1025481505537 · Cited by 185
Self-citationObesity at Diagnosis of Breast Carcinoma Influences Duration of Disease-free Survival
Senie, R. T., Rosen, P. P., Rhodes, P., Lesser, M. L., & Kinne, D. W. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-26 · Cited by 180
Rosner, G. L., Hargis, J. B., Hollis, D. R., Budman, D. R., Weiss, R. B., Henderson, I. C., & Schilsky, R. L. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.11.3000 · Cited by 178
Bastarrachea, J., Hortobagyi, G. N., Smith, T. L., Kau, S.-W. C., & Buzdar, A. U. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-1-199401010-00004 · Cited by 171
Poikonen‐Saksela, P., Saarto, T., Lundin, J. E., Joensuu, H., & BLOMQVIST, C. P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690594 · Cited by 113
Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients
Powis, G., Reece, P. A., Ahmann, D. L., & Ingle, J. N. (1987) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00570489 · Cited by 112
Medical practice variations: changing the theoretical approach
Westert, G. P., & Groenewegen, P. (1999) · Scandinavian Journal of Public Health · doi:10.1177/14034948990270030801 · Cited by 98
Body mass index in young adulthood and cancer mortality: a retrospective cohort study
Okasha, M., McCarron, P., McEwen, J., & Smith, G. D. (2002) · Journal of Epidemiology & Community Health · doi:10.1136/jech.56.10.780 · Cited by 77
Are medical oncologists biased in their treatment of the large woman with breast cancer?
Madarnas, Y., Sawka, C. A., Franssen, E., & Bjarnason, G. A. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1010635328299 · Cited by 65
Poikonen, C. B. P. (2001) · Acta Oncologica · doi:10.1080/028418601750071082 · Cited by 65
Formulas for Calculating Body Surface Area
van der Sijs, H., & Guchelaar, H. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a134 · Cited by 29
Rs, G., Dc, T., Betensky, R. A., Mansour, E. G., Hc, F., Falkson, G., Creech, R. H., & Haller, D. G. (1987) · PubMed · Cited by 17
Cited by
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
Protani, M., Coory, M., & Martin, J. H. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0990-0 · Cited by 962
Obesity as a Major Risk Factor for Cancer
De Pergola, G., & Silvestris, F. (2013) · Journal of Obesity · doi:10.1155/2013/291546 · Cited by 959
Wolin, K. Y., Carson, K., & Colditz, G. A. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0285 · Cited by 778
Pressoir, M., Desné, S., Berchery, D., Rossignol, G., Poiree, B., Meslier, M., Traversier, S., Vittot, M., Simon, M., Gekiere, J. P., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605578 · Cited by 668
Obesity and cancer risk: evidence, mechanisms, and recommendations
Vucenik, I., & Stains, J. P. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06750.x · Cited by 571
Metadata
- Authors
- Griggs, J. J., Sorbero, M. E. S., & Lyman, G. H.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2005-06-13
- Volume
- 165
- Issue
- 11
- Pages
- 1267
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W1976568734
- Cited by
- 289
- References
- 28
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.